These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 39292108)

  • 1. HIV-1 controllers exhibit an enhanced antiretroviral innate state characterised by overexpression of p21 and MCPIP1 and silencing of ERVK-6 RNA expression.
    de Azevedo SSD; Ribeiro-Alves M; Côrtes FH; Delatorre E; Hoagland B; Villela LM; Grinsztejn B; Veloso VG; Morgado MG; Souza TML; Bello G
    Mem Inst Oswaldo Cruz; 2024; 119():e240071. PubMed ID: 39292108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased expression of CDKN1A/p21 in HIV-1 controllers is correlated with upregulation of ZC3H12A/MCPIP1.
    de Azevedo SSD; Ribeiro-Alves M; Côrtes FH; Delatorre E; Spangenberg L; Naya H; Seito LN; Hoagland B; Grinsztejn B; Veloso VG; Morgado MG; Souza TML; Bello G
    Retrovirology; 2020 Jul; 17(1):18. PubMed ID: 32615986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1 infection leads to increased transcription of human endogenous retrovirus HERV-K (HML-2) proviruses in vivo but not to increased virion production.
    Bhardwaj N; Maldarelli F; Mellors J; Coffin JM
    J Virol; 2014 Oct; 88(19):11108-20. PubMed ID: 25056891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of human endogenous retrovirus (HERV) transcription during persistent and de novo HIV-1 infection.
    Vincendeau M; Göttesdorfer I; Schreml JM; Wetie AG; Mayer J; Greenwood AD; Helfer M; Kramer S; Seifarth W; Hadian K; Brack-Werner R; Leib-Mösch C
    Retrovirology; 2015 Mar; 12():27. PubMed ID: 25886562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-HERV-K (HML-2) capsid antibody responses in HIV elite controllers.
    de Mulder M; SenGupta D; Deeks SG; Martin JN; Pilcher CD; Hecht FM; Sacha JB; Nixon DF; Michaud HA
    Retrovirology; 2017 Aug; 14(1):41. PubMed ID: 28830571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-1 Infection of Primary CD4
    Young GR; Terry SN; Manganaro L; Cuesta-Dominguez A; Deikus G; Bernal-Rubio D; Campisi L; Fernandez-Sesma A; Sebra R; Simon V; Mulder LCF
    J Virol; 2018 Jan; 92(1):. PubMed ID: 29046457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of human endogenous retroviral elements in the blood of HIV-1-infected individuals.
    Contreras-Galindo R; Kaplan MH; Contreras-Galindo AC; Gonzalez-Hernandez MJ; Ferlenghi I; Giusti F; Lorenzo E; Gitlin SD; Dosik MH; Yamamura Y; Markovitz DM
    J Virol; 2012 Jan; 86(1):262-76. PubMed ID: 22031938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do Antiretroviral Drugs Protect From Multiple Sclerosis by Inhibiting Expression of MS-Associated Retrovirus?
    Morandi E; Tanasescu R; Tarlinton RE; Constantin-Teodosiu D; Gran B
    Front Immunol; 2018; 9():3092. PubMed ID: 30740110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous retroelement expression in the gut microenvironment of people living with HIV-1.
    Dopkins N; Fei T; Michael S; Liotta N; Guo K; Mickens KL; Barrett BS; Bendall ML; Dillon SM; Wilson CC; Santiago ML; Nixon DF
    EBioMedicine; 2024 May; 103():105133. PubMed ID: 38677181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human endogenous retrovirus expression is inversely associated with chronic immune activation in HIV-1 infection.
    Ormsby CE; Sengupta D; Tandon R; Deeks SG; Martin JN; Jones RB; Ostrowski MA; Garrison KE; Vázquez-Pérez JA; Reyes-Terán G; Nixon DF
    PLoS One; 2012; 7(8):e41021. PubMed ID: 22879884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NF-κB and IRF1 Induce Endogenous Retrovirus K Expression via Interferon-Stimulated Response Elements in Its 5' Long Terminal Repeat.
    Manghera M; Ferguson-Parry J; Lin R; Douville RN
    J Virol; 2016 Oct; 90(20):9338-49. PubMed ID: 27512062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of the human endogenous retrovirus K (HML-2) transcriptome by the HIV-1 Tat protein.
    Gonzalez-Hernandez MJ; Cavalcoli JD; Sartor MA; Contreras-Galindo R; Meng F; Dai M; Dube D; Saha AK; Gitlin SD; Omenn GS; Kaplan MH; Markovitz DM
    J Virol; 2014 Aug; 88(16):8924-35. PubMed ID: 24872592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trans-activation, post-transcriptional maturation, and induction of antibodies to HERV-K (HML-2) envelope transmembrane protein in HIV-1 infection.
    Michaud HA; de Mulder M; SenGupta D; Deeks SG; Martin JN; Pilcher CD; Hecht FM; Sacha JB; Nixon DF
    Retrovirology; 2014 Jan; 11():10. PubMed ID: 24472118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The interaction of human immunodeficiency virus-1 and human endogenous retroviruses in patients (primary cell cultures) and cell line models.
    Mantovani F; Kitsou K; Paraskevis D; Lagiou P; Magiorkinis G
    Microbiol Spectr; 2023 Dec; 11(6):e0137923. PubMed ID: 37811936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD4+ T cells from elite controllers resist HIV-1 infection by selective upregulation of p21.
    Chen H; Li C; Huang J; Cung T; Seiss K; Beamon J; Carrington MF; Porter LC; Burke PS; Yang Y; Ryan BJ; Liu R; Weiss RH; Pereyra F; Cress WD; Brass AL; Rosenberg ES; Walker BD; Yu XG; Lichterfeld M
    J Clin Invest; 2011 Apr; 121(4):1549-60. PubMed ID: 21403397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of human endogenous retrovirus type K (HML-2) is activated by the Tat protein of HIV-1.
    Gonzalez-Hernandez MJ; Swanson MD; Contreras-Galindo R; Cookinham S; King SR; Noel RJ; Kaplan MH; Markovitz DM
    J Virol; 2012 Aug; 86(15):7790-805. PubMed ID: 22593154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HERV-K-specific T cells eliminate diverse HIV-1/2 and SIV primary isolates.
    Jones RB; Garrison KE; Mujib S; Mihajlovic V; Aidarus N; Hunter DV; Martin E; John VM; Zhan W; Faruk NF; Gyenes G; Sheppard NC; Priumboom-Brees IM; Goodwin DA; Chen L; Rieger M; Muscat-King S; Loudon PT; Stanley C; Holditch SJ; Wong JC; Clayton K; Duan E; Song H; Xu Y; SenGupta D; Tandon R; Sacha JB; Brockman MA; Benko E; Kovacs C; Nixon DF; Ostrowski MA
    J Clin Invest; 2012 Dec; 122(12):4473-89. PubMed ID: 23143309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strong human endogenous retrovirus-specific T cell responses are associated with control of HIV-1 in chronic infection.
    SenGupta D; Tandon R; Vieira RG; Ndhlovu LC; Lown-Hecht R; Ormsby CE; Loh L; Jones RB; Garrison KE; Martin JN; York VA; Spotts G; Reyes-Terán G; Ostrowski MA; Hecht FM; Deeks SG; Nixon DF
    J Virol; 2011 Jul; 85(14):6977-85. PubMed ID: 21525339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of molecular mechanisms for achieving HIV-1 control in the absence of antiretroviral therapy.
    Hu X; Ni Y; Wang F; Ni Z; Jin T; Li Y; Ni M
    Life Sci; 2021 Jan; 265():118857. PubMed ID: 33301809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-Depth Characterization of Full-Length Archived Viral Genomes after Nine Years of Posttreatment HIV Control.
    Trémeaux P; Lemoine F; Mélard A; Gousset M; Boufassa F; Orr S; Monceaux V; Gascuel O; Lambotte O; Hocqueloux L; Saez-Cirion A; Rouzioux C; Avettand-Fenoel V
    Microbiol Spectr; 2023 Feb; 11(1):e0326722. PubMed ID: 36692300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.